Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
ALXNShowing 0 of 4 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Farallon Capital Management held 7,707,500 shares of ALXN (Alexion Pharmaceuticals), worth $1.4B. Farallon Capital Management's 13F filings listed ALXN from Q4 2020 to Q2 2021, 3 quarterly filings. ALXN was 5.8% of Farallon Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP